| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 02/21/2008 | WO2008020747A1 A method for obtaining stable micro-emulsions of derivatives of oxycarotenoids of short-chain organic acids, micro-emulsions obtained, and formulation which contains these |
| 02/21/2008 | WO2008020588A1 System for evaluating mastication function and artificial food mass |
| 02/21/2008 | WO2008020584A1 Stable lyophilized preparation |
| 02/21/2008 | WO2008020491A1 Therapeutic agent for pigmented skin lesion |
| 02/21/2008 | WO2008020421A2 Compositions comprising calcium citrate malate and methods for making the same |
| 02/21/2008 | WO2008020420A2 Compositions comprising calcium citrate malate and methods for making the same |
| 02/21/2008 | WO2008020286A2 Pharmaceutical compositions of duloxetine |
| 02/21/2008 | WO2008020221A2 Topical application of fsh, lh, tsh or cg to the cervix |
| 02/21/2008 | WO2008020218A1 Adsorption and release of nitric oxide in metal organic frameworks |
| 02/21/2008 | WO2008020217A1 Drug capsules for dry powder inhalers |
| 02/21/2008 | WO2008020126A2 Supramolecular co-colloids produced using macrocyclic polyanionic systems |
| 02/21/2008 | WO2008019996A2 Formulations of flibanserin and method for manufacturing the same |
| 02/21/2008 | WO2008019854A1 Pharmaceutical compositions easy to swallow, not causing any unpleasant oral sensation and comprising particles with an active principle |
| 02/21/2008 | WO2008019773A1 Emulsion concentrate |
| 02/21/2008 | WO2008019712A1 Pharmaceutical composition with controlled active ingredient delivery for active ingredients with good solubility in water |
| 02/21/2008 | WO2008006714A3 Improvements relating to biocidal compositions |
| 02/21/2008 | WO2008005676A3 Injectable collagen material |
| 02/21/2008 | WO2008005217A3 Iron(ii)-containing treatments for hyperphosphatemia |
| 02/21/2008 | WO2008003329A3 Nanoparticles for nucleic acid delivery |
| 02/21/2008 | WO2008001240A3 Transdermal delivery of oleocanthal for relief of inflammation |
| 02/21/2008 | WO2007149771A3 Punctal plugs for the delivery of active agents |
| 02/21/2008 | WO2007149520A3 Compositions for sustained release of nitric oxide, methods of preparing same and uses thereof |
| 02/21/2008 | WO2007146805A3 Methods to administer solid dosage forms of ethinyl estradiol and prodrugs thereof with improved bioavailabilty |
| 02/21/2008 | WO2007144085A8 Opioid combination wafer |
| 02/21/2008 | WO2007143607A3 Method of treating atrophic vaginitis |
| 02/21/2008 | WO2007142546A3 Sustained release coated tablet with precisely regulated release profile |
| 02/21/2008 | WO2007125545A3 Transmucosal composition |
| 02/21/2008 | WO2007119601A3 Nanoparticles comprising a pdgf receptor tyrosine kinase inhibitor |
| 02/21/2008 | WO2007110152A3 Polylactide nanoparticles |
| 02/21/2008 | WO2007100822A3 Fluvastatin sodium pharmaceutical compositions |
| 02/21/2008 | WO2007095149B1 Press-fit rapid release medicament and method and apparatus of manufacturing |
| 02/21/2008 | WO2007090393A3 Microtablet-based pharmaceutical preparation |
| 02/21/2008 | WO2007086541A3 Pharmaceutical composition comprising a bi-cyclic compound and method for stabilizing the bi-cyclic compound |
| 02/21/2008 | WO2007086079A3 Sustained release dosage form of phenothiazine derivatives containing channelizer |
| 02/21/2008 | WO2007075980A3 Lansoprazole orally disintegrating tablets |
| 02/21/2008 | WO2007073525A3 Hot-flash wipes and clothing |
| 02/21/2008 | WO2007068934A3 Pharmaceutical combination comprising nucleotide and nucleoside reverse transcriptase inhibitors (such as tenofovir and lamivudine) in different parts of the dosage unit |
| 02/21/2008 | WO2007027560A8 Formulation and method for enhancement of gastrointestinal absorption of pharmaceutical agents |
| 02/21/2008 | WO2007021168A8 Sublingual solid pharmaceutical formulations containing meloxicam |
| 02/21/2008 | WO2006060759B1 A sterically stabilized liposome and triamcinolone composition for treating the respiratory tract of a mammal |
| 02/21/2008 | WO2006032091A3 Herbal composition |
| 02/21/2008 | WO1999059544A9 Orally disintegrable tablets |
| 02/21/2008 | US20080045932 Unit Implantable Into a Living Body, Injection Medical System and Chronotherapeitic |
| 02/21/2008 | US20080045930 System and Method of Drug Identification Through Radio Frequency Identification (RFID) |
| 02/21/2008 | US20080045584 Use of Docetaxel for Treating Hepatocellular Carcinoma |
| 02/21/2008 | US20080045553 Transdermal Administration of Phycotoxins |
| 02/21/2008 | US20080045476 Methods and compositions using sulodexide for the treatment of diabetic nephropathy |
| 02/21/2008 | US20080045449 Novel Lipid Mixtures For Synthetic Surfactants |
| 02/21/2008 | US20080044486 Controlled Food Effect Composition |
| 02/21/2008 | US20080044485 increased viscosity of the injection vehicle that constitutes the fluid phase of the suspension significantly reduces in vivo injectability failures; microparticles; drugs such as risperidone |
| 02/21/2008 | US20080044484 Use of polymeric nanoparticles for vaccine delivery |
| 02/21/2008 | US20080044483 Metal Oxide Composition |
| 02/21/2008 | US20080044482 Orally administrable opioid formulations having extended duration of effect |
| 02/21/2008 | US20080044481 Microparticles for Oral Delivery |
| 02/21/2008 | US20080044480 Technical process and plant for the production of coacervate capsules |
| 02/21/2008 | US20080044479 Antimicrobial sanitizing formulations with skin protection properties |
| 02/21/2008 | US20080044478 Preparation of injectable suspensions having improved injectability |
| 02/21/2008 | US20080044477 Adsorbent for an Oral Administration, and Agent for Treating or Preventing Renal or Liver Disease |
| 02/21/2008 | US20080044476 Mixture of corticosteroid and sodium hyaluronate in aqueous carrier |
| 02/21/2008 | US20080044475 Forming microemulsions of diacetates and dipropionates of lutein, 3'epilutein, zeaxanthin, isozeaxanthin, mesozeaxanthin, capsanthin, capsorubin, or astaxanthin, or a monoacetate or monopropionate of cryptoxanthin; nutrition supplements; pigmenting skin of broilers and egg yolks. |
| 02/21/2008 | US20080044474 Dispersions of nanoureas comprising biologically active compounds |
| 02/21/2008 | US20080044473 Methods of reducing nervous system glial scar formation using cyclosporine components |
| 02/21/2008 | US20080044472 Photoresponsive Hydrogels |
| 02/21/2008 | US20080044471 Neurotherapeutic compositions |
| 02/21/2008 | US20080044470 Pharmaceutical composition with controlled acitve ingredient release for active ingredients with good solubility in water |
| 02/21/2008 | US20080044469 Rapidly Dispersible, Fine-Particle Film-Coating Composition Which is in Powder Form, is not Prone to Segregation and is Baased on Polyvinyl Alcohol-Polyether Graft Copolymers Characterized by Particular Physical Stability and Low Asperity |
| 02/21/2008 | US20080044468 Processes For The Preparation Of Oral Dosage Formulations Of Modafinil |
| 02/21/2008 | US20080044467 Formulation and process for drug loaded cores |
| 02/21/2008 | US20080044466 Antibacterial optically pure benzoquinolizine carboxylic acids, processes, compositions and methods of treatment |
| 02/21/2008 | US20080044465 Therapy for cellular accumulation in chronic inflammatory diseases |
| 02/21/2008 | US20080044464 Liposome loading with metal ions |
| 02/21/2008 | US20080044463 Bradykinin B2 Receptor Antagonist Peptide From Amphibian Skin |
| 02/21/2008 | US20080044462 Stabilized transdermal bupropion preparations |
| 02/21/2008 | US20080044461 Transdermal methods and systems for treating Alzheimer's disease |
| 02/21/2008 | US20080044459 Enzymatic debridement therapy for abnormal cell proliferation |
| 02/21/2008 | US20080044457 Antitumor agents; time-release agents; pulverization |
| 02/21/2008 | US20080044456 Cellulose membrane drying process |
| 02/21/2008 | US20080044455 Tonsillitus Treatment |
| 02/21/2008 | US20080044454 Protectively coated controlled release particles distributed throughout water soluble film delivery agent; easy oral delivery for patients having difficulty swallowing tablets |
| 02/21/2008 | US20080044452 Drug delivery system for treatment of transitional cell carcinoma |
| 02/21/2008 | US20080044450 Sustained Release Composition |
| 02/21/2008 | US20080044444 Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof |
| 02/21/2008 | US20080044389 Mortierella schmuckeri microorganisms are cultured in fermentation medium; a polyunsaturated fatty acid for use in food products, nutraceuticals e.g. infant formulas |
| 02/21/2008 | US20080044388 Method for Production of Arachidonic Acid |
| 02/21/2008 | US20080044361 The invention relates to propellant gas formulations containing suspensions of the crystalline monohydrate of (1 7-((hydroxydi-2-thienylacetyl)oxy)-9, 9-dimethyl-3-oxa-9-azoniatricyclo(3.3.1.02,4)nonane-bromide, with a simple monoclinic cell, and one or more adjuvants |
| 02/21/2008 | DE202007015419U1 Präparat zur Reduzierung von Viren, Keimen und Bakterien in Innenräumen als Spray A preparation for reduction of viruses, germs and bacteria indoors as a spray |
| 02/21/2008 | DE202007015298U1 Raucherentwöhnungsdosieraerosol Raucherentwöhnungsdosieraerosol |
| 02/21/2008 | DE102006038940A1 Dispersionen von Nanoharnstoffen, enthaltend Wirkstoffe Dispersions of nano-ureas containing active ingredients |
| 02/21/2008 | DE102006038629A1 Stabilisierte Wirkstoffzusammensetzung Stabilized drug composition |
| 02/21/2008 | CA2696577A1 Adsorption and release of nitric oxide in metal organic frameworks |
| 02/21/2008 | CA2678051A1 Peptides that target to tumor blood vessels of lung cancer and applications thereof |
| 02/21/2008 | CA2664919A1 Multistage delivery of active agents |
| 02/21/2008 | CA2661575A1 Pharmaceutical compositions easy to swallow, not causing any unpleasant oral sensation and comprising particles with an active principle |
| 02/21/2008 | CA2661561A1 Pharmaceutical composition with controlled active ingredient delivery for active ingredients with good solubility in water |
| 02/21/2008 | CA2660991A1 Compositions comprising calcium citrate malate and methods for making the same |
| 02/21/2008 | CA2660480A1 Aerosol formulation for the inhalation of beta agonists |
| 02/21/2008 | CA2660476A1 Formulations of flibanserin and method for manufacturing the same |
| 02/21/2008 | CA2660373A1 Methods and compositions for needleless delivery of particles |
| 02/21/2008 | CA2660295A1 Supramolecular co-colloids produced using macrocyclic polyanionic systems |
| 02/21/2008 | CA2660229A1 Administration of high potency platinum compound formulations by inhalation |